Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Study to evaluate efficacy and tolerability of Micardis® plus under usual daily-practice prescribing-conditions

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan

Criteria

Inclusion Criteria:

• Adult (Age >= 18 years) males and females for whom a medical antihypertensive therapy is indicated

Exclusion Criteria:

• Age < 18 years